Altimmune, Inc. (ALT)

Altimmune Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	532	513	604	808	363	417
Market Cap Growth	2.43%	-15.16%	-25.23%	122.62%	-12.91%	1369.44%
Enterprise Value	337	375	464	608	165	212
Last Close Price	5.10	7.21	11.25	16.45	9.16	11.28
PS Ratio	26607.31	25640.43	1418.90	-11888.90	82.35	50.95
PB Ratio	2.63	4.15	3.11	4.36	1.82	1.85
P/TBV Ratio	2.87	4.15	3.11	4.68	1.95	1.96
EV/Sales Ratio	16863.76	18760.08	1090.28	-	37.39	25.91
Debt / Equity Ratio	0.09	0.01	0.00	0.01	0.01	0.01
Asset Turnover	0	0	0.00	-	0.02	0.06
Quick Ratio	16.83	12.90	16.69	10.99	10.73	18.99
Current Ratio	17.18	13.11	17.26	11.31	11.17	19.16
Return on Equity (ROE)	-52.62%	-59.86%	-46.63%	-44.07%	-45.69%	-36.14%
Return on Assets (ROA)	-30.87%	-36.85%	-25.00%	-25.73%	-22.86%	-16.10%
Return on Capital (ROIC)	-33.59%	-40.31%	-27.38%	-28.31%	-24.76%	-17.52%
Return on Capital Employed (ROCE)	-43.90%	-80.10%	-42.10%	-46.20%	-42.30%	-16.50%
Earnings Yield	-15.77%	-18.54%	-14.63%	-10.48%	-26.74%	-11.76%
FCF Yield	-12.47%	-15.57%	-12.55%	-7.76%	-24.88%	-8.28%
Buyback Yield / Dilution	-17.16%	-33.35%	-13.47%	-13.67%	-61.03%	-95.33%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q